MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-18-2026
InspireMD Total Assets 2011-2026 | NSPR
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets InspireMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.4 M | 46.8 M | 47.6 M | 24.7 M | 39.7 M | 17.8 M | 9.88 M | 12.3 M | 6.11 M | 9.41 M | 5.78 M | 11.5 M | 20.7 M | 16 M | 10.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 69.4 M | 5.78 M | 23.2 M |
Quarterly Total Assets InspireMD
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.5 M | 33.3 M | 38.7 M | 46.8 M | 50.5 M | 55.7 M | 42 M | 47.6 M | 50 M | 53.6 M | 19.9 M | 24.7 M | 28.1 M | 32.8 M | 35.2 M | 39.7 M | 42.6 M | 46.4 M | 48.6 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 9.88 M | 9.88 M | 9.88 M | 9.88 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 6.11 M | 6.11 M | 6.11 M | 6.11 M | 9.41 M | 9.41 M | 9.41 M | 9.41 M | 5.69 M | 5.69 M | 5.69 M | 5.69 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 24 M | 24 M | 24 M | 24 M | 11.6 M | 13.6 M | 16 M | 16 M | 10.5 M | 12.1 M | 11.3 M | 10.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 78.5 M | 5.69 M | 22.1 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.24 | 1.7 % | $ 1.65 B |  USA |
 |
Apyx Medical Corporation
APYX
|
66.8 M | $ 3.84 | 4.21 % | $ 158 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 10.96 | 1.2 % | $ 1.64 B | USA |
 |
AxoGen
AXGN
|
222 M | $ 33.3 | -3.31 % | $ 1.53 B | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 4.09 | -0.61 % | $ 866 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 36.54 | -0.58 % | $ 5.44 K | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 62.41 | -0.65 % | $ 92.4 B | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.32 | -0.48 % | $ 264 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 34.67 | -0.34 % | $ 1.08 B | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.6 | 2.73 % | $ 37.3 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.76 | 1.35 % | $ 350 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.43 | 1.18 % | $ 128 M |  France |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 80.92 | -0.16 % | $ 47.3 B | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.59 | - | $ 122 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 87.63 | -0.33 % | $ 11.8 B | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 170.68 | 0.05 % | $ 12.8 B | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.87 | 0.54 % | $ 1.14 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.34 | -1.99 % | $ 719 M | USA |
 |
Inogen
INGN
|
299 M | $ 6.41 | 3.14 % | $ 171 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 0.99 | 1.0 % | $ 16.8 M | USA |
 |
IRadimed Corporation
IRMD
|
109 M | $ 97.04 | 0.84 % | $ 1.23 B | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 85.1 | -2.01 % | $ 2.96 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.9 | -1.0 % | $ 373 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 6.01 | -0.91 % | $ 71.9 M | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.39 | 4.14 % | $ 56.6 M | USA |
 |
Medtronic PLC
MDT
|
91.7 B | $ 86.29 | -0.39 % | $ 111 B | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 3.86 | -1.53 % | $ 570 M | USA |